What is the Ownership and Shareholding Structure of Udik Pharmaceuticals?
In 2020, Udik Pharmaceuticals had a promoter holding of 58.33% and a public holding of 41.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX